After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Cassava Sciences Inc is $157.49M. A total of 1.76 million shares were traded on the day, compared to an average of 2.56M shares.
In the most recent transaction, Cook Robert Christopher bought 13,725 shares of SAVA for 2.91 per share on Sep 30 ’25. After the transaction, the Chief Operating & Legal Office now owns 13,725 company shares. In a previous transaction on Sep 22 ’25, Barry Richard bought 7,172 shares at 2.28 per share. SAVA shares that President & CEO owns now total 714,675.
Among the insiders who bought shares, Barry Richard acquired of 190,633 shares on Sep 18 ’25 at a per-share price of $2.24. This resulted in the President & CEO holding 660,195 shares of SAVA after the transaction. In another insider transaction, Barry Richard bought 47,308 shares at $2.29 per share on Sep 19 ’25. Company shares held by the President & CEO now total 707,503.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, SAVA has a high of $33.98 and a low of $1.15.
As of this writing, SAVA has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$0.27. The company reported an EPS of -$0.22 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SAVA’s latest balance sheet shows that the firm has $233.44M in Cash & Short Term Investments as of fiscal 2021. There were $236.00k in debt and $12.53M in liabilities at the time. Its Book Value Per Share was $1.82, while its Total Shareholder’s Equity was $253.91M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SAVA is Buy with a score of 1.00.
